Skip to Content

Paion Ag PAIOF

Morningstar Rating
$0.05 +0.02 (99.20%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PAIOF is trading at a 684% premium.
Price
$0.05
Fair Value
$1.97
Uncertainty
Extreme
1-Star Price
$6.67
5-Star Price
$2.85
Economic Moat
Fwdqv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PAIOF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.03
Day Range
$0.050.05
52-Week Range
$0.026.30
Bid/Ask
$0.00 / $1.00
Market Cap
$376,318.95
Volume/Avg
60,000 / 7,895

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.01
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Paion Ag is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
64

Comparables

Valuation

Metric
PAIOF
BIO
ICVX
Price/Earnings (Normalized)
8.45
Price/Book Value
3.123.30
Price/Sales
0.012.05
Price/Cash Flow
9.05
Price/Earnings
PAIOF
BIO
ICVX

Financial Strength

Metric
PAIOF
BIO
ICVX
Quick Ratio
0.510.8817.59
Current Ratio
0.762.0418.06
Interest Coverage
−5.025.92
Quick Ratio
PAIOF
BIO
ICVX

Profitability

Metric
PAIOF
BIO
ICVX
Return on Assets (Normalized)
−51.27%13.98%−29.30%
Return on Equity (Normalized)
−291.82%41.79%−31.87%
Return on Invested Capital (Normalized)
−63.45%19.73%−34.69%
Return on Assets
PAIOF
BIO
ICVX
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRSqhccfrptlFtlnrg$78.2 Bil
ZTS
Zoetis Inc Class AXbwjjrlkTytg$78.0 Bil
HLN
Haleon PLC ADRYtbjbhxFpvq$37.4 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRPsksybpmDhk$19.1 Bil
VTRS
Viatris IncLmnghrkZrgb$12.4 Bil
RDY
Dr Reddy's Laboratories Ltd ADRYmpqlnkDnpb$11.8 Bil
CTLT
Catalent IncTqzrtxfbSnybhwz$9.9 Bil
PRGO
Perrigo Co PLCXpcqgfsbGwcdw$3.8 Bil
CURLF
Curaleaf Holdings IncKzyyszlbDhkf$3.5 Bil
PBH
Prestige Consumer Healthcare IncCxcczghkBbldn$3.2 Bil

Sponsor Center